FJU‐C28 inhibits the endotoxin‐induced pro‐inflammatory cytokines expression via suppressing JNK, p38 MAPK and NF‐κB signaling pathways

por Jung, Fang, Liu, Jung‐Sen, Yang, Shih‐Hsing, Tseng, Hui‐Yun, Chou, Shang‐Shing P., Lin, Jau‐Chen, Jow, Guey‐Mei
Publicado 2021

Induction of p53-independent growth inhibition in lung carcinoma cell A549 by gypenosides

por Liu, Jung-Sen, Chiang, Tzu-Hsuan, Wang, Jinn-Shyan, Lin, Li-Ju, Chao, Wei-Chih, Inbaraj, Baskaran Stephen, Lu, Jyh-Feng, Chen, Bing-Huei
Publicado 2015

Prediction consistency and clinical presentations of breast cancer molecular subtypes for Han Chinese population

por Huang, Chi-Cheng, Tu, Shih-Hsin, Lien, Heng-Hui, Jeng, Jaan-Yeh, Liu, Jung-Sen, Huang, Ching-Shui, Wu, Yih-Yiing, Liu, Chih-Yi, Lai, Liang-Chuan, Chuang, Eric Y
Publicado 2012

FJU-C4, a New 2-Pyridone Compound, Attenuates Lipopolysaccharide-Induced Systemic Inflammation via p38MAPK and NF-κB in Mice

por Liu, Jung-Sen, Jung, Fang, Yang, Shih-Hsing, Chou, Shang-Shing P., Huang, Jhih-Liang, Lu, Chang-Lin, Huang, Guan-Lin, Yang, Pan-Chyr, Lin, Jau-Chen, Jow, Guey-Mei
Publicado 2013